PGI5 THE COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2B (I2KD) PLUS RIBAVIRIN VS. INTERFERON ALFA-2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (CHC) IN A DEVELOPING COUNTRY—BRAZIL
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67512-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)67512-2/fulltext
Title :
PGI5 THE COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2B (I2KD) PLUS RIBAVIRIN VS. INTERFERON ALFA-2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (CHC) IN A DEVELOPING COUNTRY—BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67512-2&doi=10.1016/S1098-3015(10)67512-2
First page :
Section Title :
Open access? :
No
Section Order :
79